Ryan T Sullivan Insider Trading $ICPT INTERCEPT PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Ryan T Sullivan.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Ryan T Sullivan. Ryan T Sullivan is General Counsel in INTERCEPT PHARMACEUTICALS INC ($ICPT) and General Counsel and Secretary in INTERCEPT PHARMACEUTICALS, INC. ($ICPT) and VP, General Counsel & Secr. in Warner Chilcott plc ($WCRX) and EVP and General Counsel in Anacor Pharmaceuticals, Inc. ($ANAC) and Sr. VP and General Counsel in Anacor Pharmaceuticals, Inc. ($ANAC).

Ryan T Sullivan in INTERCEPT PHARMACEUTICALS, INC.

Trading Symbol: ICPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ryan T Sullivan: General Counsel and Secretary, General Counsel
Holdings: 24,708 shares
Current Value: $2,806,088
Latest Transaction: Nov 16 2020
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Ryan T Sullivan in INTERCEPT PHARMACEUTICALS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ANAC, ICPT, WCRX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 16 2020ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Payment of ExerciseF37.8749318,67024,70825.2 K to 24.7 K (-1.96 %)
Aug 14 2020ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Payment of ExerciseF51.8649325,56725,20125.7 K to 25.2 K (-1.92 %)
May 14 2020ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Payment of ExerciseF85.0849341,94425,69426.2 K to 25.7 K (-1.88 %)
Feb 14 2020ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Payment of ExerciseF94.6949346,68226,18726.7 K to 26.2 K (-1.85 %)
Jan 27 2020ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Option ExerciseA99.669,200916,8729,200
Jan 27 2020ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...GrantA0.005,600026,68021.1 K to 26.7 K (+26.57 %)
Jan 03 2020ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Payment of ExerciseF123.92809100,25121,08021.9 K to 21.1 K (-3.70 %)
Nov 19 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Option ExerciseM53.418,325444,63826,475
Nov 19 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Option ExerciseM53.418,325444,63826,475
Nov 19 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...SellS85.003,829325,46521,88925.7 K to 21.9 K (-14.89 %)
Nov 19 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...SellS85.003,829325,46521,88925.7 K to 21.9 K (-14.89 %)
Nov 19 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...SellS85.008,325707,62525,71834 K to 25.7 K (-24.45 %)
Nov 19 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...SellS85.008,325707,62525,71834 K to 25.7 K (-24.45 %)
Nov 19 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...BuyM53.418,325444,63834,04325.7 K to 34 K (+32.37 %)
Nov 19 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...BuyM53.418,325444,63834,04325.7 K to 34 K (+32.37 %)
Nov 15 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Option ExerciseM53.4150026,70534,800
Nov 15 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Payment of ExerciseF83.9271159,66725,71826.4 K to 25.7 K (-2.69 %)
Nov 15 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...SellS85.0050042,50026,42926.9 K to 26.4 K (-1.86 %)
Nov 15 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...BuyM53.4150026,70526,92926.4 K to 26.9 K (+1.89 %)
Aug 14 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Payment of ExerciseF66.0368945,49526,42927.1 K to 26.4 K (-2.54 %)
May 14 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Payment of ExerciseF83.7371159,53227,11827.8 K to 27.1 K (-2.55 %)
Feb 14 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Payment of ExerciseF110.351,971217,50027,82929.8 K to 27.8 K (-6.61 %)
Jan 18 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Option ExerciseA110.8010,7001,185,56010,700
Jan 18 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...GrantA0.006,600029,80023.2 K to 29.8 K (+28.45 %)
Feb 15 2018ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral CounselOption ExerciseA53.4135,3001,885,37335,300
Feb 15 2018ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral CounselGrantA0.0023,200023,2000 to 23.2 K

Page:   1